Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C
NCT ID: NCT00643695
Last Updated: 2016-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2008-03-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Central Hypothesis Veterans who receive the exercise intervention will be significantly less symptomatic for depression than veterans in the control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Depressive Symptoms During HCV Therapy: A Randomized Study
NCT00495768
Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients
NCT00596960
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
NCT01143896
A Health Intervention to Prevent Depression Hepatitis C Patients
NCT01890083
Improving Quality of Life for Veterans Undergoing Interferon Treatment
NCT00117559
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Home-based walking program
Home-based walking program
The exercise intervention is a 12 week home-based exercise program. Ideally Individuals will walk for 30 minutes, at a moderate intensity, a minimum of three times per week. However, the duration and relative intensity will be tailored for each individual.
2
educational intervention
Educational intervention
Participants in the control group will receive a packet of information regarding hepatitis C
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home-based walking program
The exercise intervention is a 12 week home-based exercise program. Ideally Individuals will walk for 30 minutes, at a moderate intensity, a minimum of three times per week. However, the duration and relative intensity will be tailored for each individual.
Educational intervention
Participants in the control group will receive a packet of information regarding hepatitis C
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documentation of positive hepatitis C status as indicated by a detectable HCV viral load by polymerase chain reaction
* Mild to moderate depressive symptoms as evidenced by a BDI II score of ≥ 14
* Able to read and understand English
* Written/signed informed consent specific to this protocol
* Being sedentary that is , less than 30 minutes of planned low to moderate intensity exercise 2 days per week
Exclusion Criteria
* Current interferon therapy or planning to begin interferon therapy during the next three months
* Diagnosis of Bipolar disorder, Schizophrenia, or Post Traumatic Stress Disorder
* Any medical condition, disorder, or medication that contraindicates participation in a mild to moderate intensity walking program
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Portland VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patricia Taylor-Young
Nurse Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia Taylor-Young, PhD, RN,FNP
Role: PRINCIPAL_INVESTIGATOR
Portland VA Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Portland VA Medical Center
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.